KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $49.2 million.

  • Charles River Laboratories International's Shares Outstanding (Weighted Average) fell 4.68% to $49.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.2 million, marking a year-over-year decrease of 4.68%. This contributed to the annual value of $51.1 million for FY2024, which is 0.31% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Shares Outstanding (Weighted Average) stood at $49.2 million, which was up 0.20% from $49.1 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Shares Outstanding (Weighted Average) ranged from a high of $51.6 million in Q3 2024 and a low of $49.1 million during Q2 2025.
  • For the 3-year period, Charles River Laboratories International's Shares Outstanding (Weighted Average) averaged around $50.9 million, with its median value being $51.2 million (2023).
  • As far as peak fluctuations go, Charles River Laboratories International's Shares Outstanding (Weighted Average) climbed by 1.67% in 2021, and later fell by 4.68% in 2025.
  • Over the past 5 years, Charles River Laboratories International's Shares Outstanding (Weighted Average) (Quarterly) stood at $50.5 million in 2021, then rose by 0.82% to $50.9 million in 2022, then climbed by 0.82% to $51.3 million in 2023, then decreased by 0.31% to $51.1 million in 2024, then declined by 4.68% to $49.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $49.2 million in Q3 2025, compared to $49.1 million in Q2 2025 and $51.1 million in Q1 2025.